• 
  Anda Huna, Béatrice Nawrocki-Raby, Teresita Padilla-Benavides, Julie Gavard, Sylvie Coscoy, et al.. Loss of the Metastasis Suppressor NME1, But Not of Its Highly Related Isoform NME2, Induces a Hybrid Epithelial–Mesenchymal State in Cancer Cells. International Journal of Molecular Sciences, MDPI, 2021, 22 (7), pp.3718. ⟨10.3390/ijms22073718⟩. ⟨inserm-03191241⟩
• 
  Marion Dhooge, Stéphanie Baert-Desurmont, Carole Corsini, Olivier Caron, Nadine Andrieu, et al.. National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract. European Journal of Medical Genetics, Elsevier, 2020, 63 (12), pp.104080. ⟨10.1016/j.ejmg.2020.104080⟩. ⟨inserm-03182974⟩
• 
  Pacôme Fosse, Sylvie Girault, Olivier Capitain, Isabelle Valo, Francis Bouchet, et al.. Apport de la TEP-FDG dans le staging initial des cancers du sein localement avancés traités par chimiothérapie néo-adjuvante. Médecine Nucléaire, Elsevier/Masson, 2012, 36 (2), Non spécifié. ⟨10.1016/j.mednuc.2011.11.011⟩. ⟨hal-03179503⟩
• 
  Christian Jeanguillaume, Gilles Metrard, D. Ricquier, Pierre Legras, Francis Bouchet, et al.. Visualization of Activated BAT in Mice, with FDG-PET and its relation to UCP1. Advances in Molecular Imaging, 2013, 3 (3), pp.19-22. ⟨10.4236/ami.2013.33004⟩. ⟨hal-03179486⟩
• 
  Marisa Capitao, Justine Perrin, Sylvain Simon, Sébastien Gouard, Nicolas Chouin, et al.. Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model. Cancers, MDPI, 2021, 13 (6), pp.1256. ⟨10.3390/cancers13061256⟩. ⟨inserm-03171640⟩
• 
  M. Roger, Anne Clavreul, Laurence Sindji, Agnès Chassevent, Paul Schiller, et al.. In vitro and in vivo interactions between glioma and marrow isolated adult multilineage inducible (MIAMI) cells.. Brain Research, Elsevier, 2012, 1473, pp.193-203. ⟨hal-03165478⟩
• 
  Nunzia Iaccarino, Mingpan Cheng, Dehui Qiu, Bruno Pagano, Jussara Amato, et al.. Effects of sequence and base composition on the CD and TDS profiles of i-DNA. Angewandte Chemie International Edition, Wiley-VCH Verlag, 2021, ⟨10.1002/anie.202016822⟩. ⟨hal-03149384⟩
• 
  Valentin Calugaru, Pascal Pommier, Paul Giraud, Philippe Giraud, Eliot Nicolas, et al.. Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers. Cancers, MDPI, 2020, 13 (1), pp.57. ⟨10.3390/cancers13010057⟩. ⟨hal-03146371⟩
• 
  Valentin Partula, Mélanie Deschasaux-Tanguy, Stanislas Mondot, Agnès Victor-Bala, Nadia Bouchemal, et al.. Associations between untargeted plasma metabolomic signatures and gut microbiota composition in the Milieu Intérieur population of healthy adults. British Journal of Nutrition, Cambridge University Press (CUP), 2020, pp.1-29. ⟨10.1017/S0007114520004870⟩. ⟨hal-03073792⟩
• 
  Cindy Neuzillet, Amélie Anota, A.-M. Foucaut, Anne-Laure Védie, Sami Antoun, et al.. Nutrition and physical activity: French intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC, SFP-APA, SFNCM, AFSOS). BMJ Palliative and supportive care, BMJ Publishing Group 2020, bmjspcare-2020-002751. ⟨10.1136/bmjspcare-2020-002751⟩. ⟨hal-03038521⟩
• 
  Marion Berdal, Sébastien Gouard, Romain Eychenne, Séverine Marionneau-Lambot, Mikaël Croyal, et al.. Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chemical Science , The Royal Society of Chemistry, 2020, Online ahead of print. ⟨10.1039/D0SC05191H.⟩. ⟨inserm-03024891⟩
• 
  Catherine Uzan, Chafika Mazouni, Caroline Rossoni, Brigitte de Korvin, Christine Tunon de Lara, et al.. Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions. Annals of Surgical Oncology, Springer Verlag, 2020, ⟨10.1245/s10434-020-09107-z⟩. ⟨hal-03013819⟩
• 
  C. Chargari, S. Supiot, C. Hennequin, A. Chapel, J.-M. Simon. Traitement des effets tardifs après la radiothérapie : quoi de neuf ?. Cancer Radiothérapie, Elsevier Masson, 2020, 24 (6-7), pp.602-611. ⟨10.1016/j.canrad.2020.06.007⟩. ⟨hal-02969642⟩
• 
  Wolfgang Wick, Thierry Gorlia, Martin Bendszus, Martin Taphoorn, Felix Sahm, et al.. Lomustine and Bevacizumab in Progressive Glioblastoma. New England Journal of Medicine, Massachusetts Medical Society, 2017, 377 (20), pp.1954-1963. ⟨10.1056/NEJMoa1707358⟩. ⟨inserm-02940442⟩
• 
  Fabien Vidal, Paul Guerby, Mathieu Luyckx, Pascale Haddad, Eberhard Stoeckle, et al.. Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?. PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147787. ⟨10.1371/journal.pone.0147787⟩. ⟨inserm-02940269⟩
• 
  Florence Boissier, Valérie Seegers, Amélie Seguin, Stephane Legriel, Alain Cariou, et al.. Assessing physicians’ and nurses’ experience of dying and death in the ICU: development of the CAESAR-P and the CAESAR-N instruments. Critical Care, BioMed Central, 2020, 24 (1), ⟨10.1186/s13054-020-03191-z⟩. ⟨hal-02922649⟩
• 
  M. Caillot, J. Bourgeais, H. Dakik, É. Costé, N. Mazure, et al.. Oncogenesis Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells. Oncogenesis, Nature Publishing Group: Open Access Journals - Option C, 2020, 9 (7), pp.68. ⟨10.1038/s41389-020-00253-3⟩. ⟨hal-02908131⟩
• 
  Sylvie Négrier, Nathalie Rioux-Leclercq, Céline Ferlay, Marine Gross-Goupil, Gwénaelle Gravis, et al.. Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial. European Journal of Cancer, Elsevier, 2020, 129, pp.107 - 116. ⟨10.1016/j.ejca.2020.02.001⟩. ⟨hal-02552562⟩
• 
  Clément Palpacuer, Karima Hammas, Renan Duprez, Bruno Laviolle, John P A Ioannidis, et al.. Vibration of effects from diverse inclusion/exclusion criteria and analytical choices 9216 different ways to perform an indirect comparison meta-analysis. BMC Medicine, BioMed Central, 2019, 17 (1), pp.174. ⟨10.1186/s12916-019-1409-3⟩. ⟨hal-02304653⟩
• 
  E. Mylona, A. Cicchetti, T. Rancati, F. Palorini, S. Supiot, et al.. Predicting urinary toxicity via 2D and 3D dose map analyses in prostate cancer radiotherapy. Radiotherapy and Oncology, Elsevier, 2019, 133, pp.S326-S326. ⟨10.1016/S0167-8140(19)31035-7⟩. ⟨hal-02177166⟩

101

206